Newsletter #2
?? The prostate care news
Benefits of using MRI-targeted biopsy in Prostate cancer
Since 2022, international authorities recommend to use MRI/US system for a better diagnosis of prostate cancer. Zoom on the benefits of this procedure for urologists, but also and especially, patients.
Genetic ringleader responsible for prostate cancer spread identified
?? What's up at Koelis?
Throw back to CFU congress in Paris
Last week, we were attending the #CFU2023 in Paris and it was a success! We had the occasion to share with urologists about diagnostic and treatment of prostate cancer.
Congress after congress, we see the guidelines evolving and the urological practices too. Many studies and physicians testimonials attest to the fact that MRI is increasingly used to diagnose prostate cancer, highlighting focal therapies as a viable option for patients, and urologists of tomorrow are more and more connected. Once again this year, Koelis took center stage and was featured in several scientific sessions.
Together for Movember
Since several years, november is dedicated to men health issues. At Koelis, as expert of prostate care management, we encourage our employees to move and to talk about it around them. And, of course, to let their mustaches grow if they want to! Several activities have been organized to mobilize them.
Koelis was also very proud to follow and support the surgeon urologist Bertrand Guillonneau in his sailing adventure for Transat Jacques Vabre. Bertrand Guillonneau was carry out the colors and messages of Movember!
??Koelis is now on instagram!
?? We are hiring, join us!
If you want to know more about prostate care management, medical innovation and fusion biopsy, don't hesistate to contact us ??.